This webinar recorded on July 23, 2014 covers the following topics:
View a recording of the webinar here. View a PDF version of the slides here.
This dosing chart provides recommendations for the acceptable doses of second-line TB drugs for children. This chart, available here, was developed by a team of experts in November 2013 based on published data as well as new PK data on the fluoroquinolones and aminoglycosides. The doses are based on weight bands and use tablet sizes currently available in most TB programs. Because children being treat for DR-TB often gain weight quickly, it is recommended that dose adjustments be considered on a regular basis (i.e. monthly).
For important disclaimers on the use of this dosing chart, please refer to the disclaimer section available in the Sentinel Project’s “Management of Drug-Resistant Tuberculosis in Children: A Field Guide“
This webinar recorded on June 6, 2014 covers the following topics:
View a recording of the webinar here. View a PDF version of the slides here.
Because DR-TB is a disease of families, this webinar recorded on May 21, 2014 focuses on the impact of DR-TB on the household, specifically:
View a recording of the webinar here. View a PDF version of the slides here.
This webinar recorded on April 25, 2014 was presented by Drs. Jennifer Furin and James Seddon, members of the Sentinel Project on Pediatric Drug-Resistant Tuberculosis. This case-based discussion covers key principles for regimen construction in children with DR-TB, the latest dosing recommendation and PK data on second-line drugs in children, and the use of new TB drugs and regimens in children with DR-TB.
View a recording of the webinar here. View a PDF version of the slides here.
The Sentinel Project on Pediatric Drug-Resistant Tuberculosis (www.sentinel-project.org) has developed an 18 minute video on the gastric aspirate technique in children.
This webinar recorded on March 14, 2014 includes the video and a Q & A session on the technique with members of the Sentinel Project.
View a recording of the webinar here. View a PDF version of the Standard Operating Procedure here.
Post-graduate Course 04. Managing children with drug-resistant tuberculosis: a practical approach
Thursday, 31 October 2013, 9:00 – 17:00, Room: 341
44th Union World Conference on Lung Health, 30 October – 3 November 2013, Paris, France
Description
Despite some advances in expanding access to effective treatment for drug-resistant tuberculosis (DR-TB), children remain largely neglected. Diagnosis of DR-TB in children is perceived to be challenging and few providers have experience managing children with DR-TB. This course aimed to provide workers with practical advice and guidance to manage children with DR-TB. It addressed diagnosis, prevention, treatment, delivery of medication doses, management of adverse events, and approaches to the programmatic management of DR-TB in children.
This course was aimed at any health care worker who may manage children with drug-resistant tuberculosis. The course’s strong clinical and practical components were of use to those working in the community, clinic, hospital, or TB programme.
Presentations
Coordinators: Mercedes Becerra (USA), James Seddon (UK)
Chairs: Mercedes Becerra (USA), James Seddon (UK)
Thursday, 31 October 2013, 13:30 – 17:00, Room: 251
44th Union World Conference on Lung Health, 30 October – 3 November 2013, Paris, France
Workshop sponsored by The Stop TB Partnership
Description
Prevalence surveys are important for measuring the burden of, and trends in, TB disease. With these data, national tuberculosis programmes (NTPs) can assess the impact of their efforts,and identify the reasons why cases may not have been diagnosed. This information can then be used to identify strategies for improving the rate of case detection, attaining more timely diagnosis, and providing better treatment. However, the majority of countries continue to not include children less than 15 years of age in their national surveys of TB disease, even though they constitute approximately a third of their population.
This symposium was targeted at health policy-makers, public health officials, epidemiologists, technical advisors, patient advocates, implementers, clinicians (physicians, nurses, physiotherapists, respiratory therapists), and researchers. Its objectives were to:
1. Review the history of TB prevalence surveys that included children and the measures taken to accomplish this.
2. Review the epidemiologic science, the tools, and the related ethical considerations, for including children.
3. Review the implementation science for measuring TB burden in children, in resource-limited and -rich countries.
4. Review the reasons why the inclusion of children in national TB prevalence surveys has not been recommended.
5. Promote discussion on the inclusion of children in national prevalence surveys of TB disease.
Presentations
1. Importance and history of measuring the burden of TB disease in children
Peter Donald (South Africa)
2. The epidemiological science for measuring the burden of TB disease in children
Annelies Van Rie (USA)
3. The implementation science for measuring the burden of TB disease in children
Anneke Hesseling (South Africa)
4. Current recommendations and supportive efforts of the WHO for measuring the burden of TB disease in children
Babis Sismanidis (Switzerland)
5. Potential solutions for overcoming the challenges in measuring the burden of TB disease in children
Jeffrey Starke (USA)
6. Round-table discussion: how should countries measure their burden of TB disease in children?
Elizabeth Gardiner (USA)
Coordinators: Carlos Perez-Velez (USA), Soumya Swaminathan (India)
Chairs: Steve Graham (Australia), Carlos Perez-Velez (USA)
(Photo credit: Stop TB Partnership, Shehzad Noorani)
View a short, powerful video from Médecins Sans Frontières about MDR-TB treatment in children here.
The static URL is: